Naproxen: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
*back pain | *back pain | ||
"Naproxen and naproxen sodium are marketed under various trade names, including: Aleve, Anaprox, Antalgin, Feminax Ultra, Flanax, Inza, Midol Extended Relief, Miranax, Nalgesin, Naposin, Naprelan, Naprogesic, Naprosyn, Narocin, Proxen, Synflex and Xenobid."<ref>http://en.wikipedia.org/wiki/Naproxen</ref> Like other NSAID medications naproxen is known to cause ulcers, bleeding, or holes in the lining of the stomach and intestines and should always be taken with a glass of water. | "Naproxen and naproxen sodium are marketed under various trade names, including: '''Aleve, Anaprox, Antalgin, Feminax Ultra, Flanax, Inza, Midol Extended Relief, Miranax, Nalgesin, Naposin, Naprelan, Naprogesic, Naprosyn, Narocin, Proxen, Synflex and Xenobid'''."<ref>http://en.wikipedia.org/wiki/Naproxen</ref> Like other NSAID medications naproxen is known to cause ulcers, bleeding, or holes in the lining of the stomach and intestines and should always be taken with a glass of water. | ||
Some of naproxen's side effects, are and are not limited too: constipation, diarrhea, sores in mouth, excessive thirst, headache, | Some of naproxen's side effects, are and are not limited too: constipation, diarrhea, sores in mouth, excessive thirst, headache, | ||
dizziness, drowsiness, ringing in the ears, hearing problems. More severe symptoms such as blisters, changes in vision, rash, hives, difficulty breathing, flu-like symptoms, bloody urine, and stomach pain are also known to occur.<ref>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000526/</ref> | dizziness, drowsiness, ringing in the ears, hearing problems. More severe symptoms such as blisters, changes in vision, rash, hives, difficulty breathing, flu-like symptoms, bloody urine, and stomach pain are also known to occur.<ref>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000526/</ref> | ||
==Background Information== | |||
==Chemical Properties== | ==Chemical Properties== | ||
IUPAC:(+)-(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid | IUPAC:(+)-(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid | ||
| Line 35: | Line 37: | ||
==Synthesis== | ==Synthesis== | ||
[[Image:Synthesis.jpg]]<ref>http://en.wikipedia.org/wiki/Naproxen</ref> | [[Image:Synthesis.jpg]]<ref>http://en.wikipedia.org/wiki/Naproxen</ref> | ||
==COX-1 & COX-2 Inhibitor== | ==COX-1 & COX-2 Inhibitor== | ||
'''Cyclooxygenase''' abbreviated as '''COX''' | |||
==Naproxen In Vivo== | |||
<Structure load='3NT1' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' /> | <Structure load='3NT1' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' /> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||